Ansell Limited announced 1H FY2023 results; Sales declined 11.5%

Ansell Limited (ASX: ANN) announced 1H FY2023 results for the period ended 31 December 2022.

• ANN’s sales during the period was US$835.3 million. The Company witnessed strong growth in Industrial more than offset by lower Healthcare sales leading to an overall 11.5% decline on an organic constant currency-basis.
• EBIT stood at US$91.5 million. EBIT margins improved 120 basis points on an organic constant currency-basis.
• EPS during the period was US50.6 cents. It increased 10.1% on an organic constant currency-basis.
• Operating Cash Flow in 1H FY2023 was US$3.5 million.
• The Company announced an interim dividend of US 20.10 cents resulting in a payout ratio of 40%. It is in line with the Company’s dividend policy.

Customer Notice:

Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.

Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com